AMIX Autonomix Medical, Inc.

Overview and Growth

Fiscal 2026 results for Autonomix Medical, Inc. combined $0.00 of revenue with net loss of $16.71M and an operating cash outflow of $12.28M. The company employed $7.60M of total assets, the balance-sheet base supporting its current operating and cash-flow results.

Profitability

Operations produced a $17.03M operating loss before non-operating and tax effects. The company ended the period with a net loss of $16.71M, extending the operating result through all remaining items. Negative EBITDA totaled $17.02M, confirming that the earnings deficit remained before depreciation and amortization. The company reported a pretax loss of $16.71M, before the effect of income taxes. The company recognized $0.00 of income tax for the period, completing the transition from pretax income to net income. Relative to period-end equity, the net loss represented 283.5%. The loss-to-assets relationship was 219.9%, placing the bottom-line deficit against the company’s resource base. The bottom-line deficit increased from $11.41M in fiscal 2025 to $16.71M.

Liquidity and Capital Structure

At period end, the $7.60M asset base was financed through $1.71M of liabilities and $5.89M of equity. At period end, current assets of $7.58M compared with current liabilities of $1.71M, defining the company’s short-term resource position. At 4.45x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $7.00M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 410.8% of current liabilities, showing how much near-term coverage came from cash alone. Book equity represented 77.6% of total assets, quantifying the balance-sheet share supported by shareholder capital. Relative to total assets, liabilities measured 22.4%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 92.2%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $9.81M in fiscal 2025, the current asset base moved 22.5% and finished lower. Book equity was 27.2% lower than fiscal 2025 equity of $8.10M, showing how shareholder capital changed year over year. Cash and equivalents were 23.3% lower than fiscal 2025 cash of $9.14M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $12.28M, rather than cash generation from operations. Capital spending of $10.00K added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. The company recorded a $12.29M cash deficit after capital spending for the period. Relative to total assets, the post-investment cash deficit measured 161.7%. Compared with a $8.26M operating cash outflow in fiscal 2025, the current outflow increased to $12.28M.

Based on the annual report for the fiscal year ending Mar 31, 2026. Analysis generated Oct 21, 2026.